Please enable JavaScript to continue using this application.

Compare $AVXL vs $HURA | Chartloom

Compare

$AVXL vs $HURA

Anavex Life Sciences Corp · TuHURA Biosciences Inc

AVXL

Anavex Life Sciences Corp

HURA

TuHURA Biosciences Inc

Compare $AVXL vs $HURA

Comparing Anavex Life Sciences Corp and TuHURA Biosciences Inc

AVXLAnavex Life Sciences Corp

HURATuHURA Biosciences Inc

AVXLAnavex Life Sciences Corp

Market cap

$138M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-59.5%

52W performance

-84.9%

FCF yield

-21.2%

HURATuHURA Biosciences Inc

Market cap

$125M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

161.3%

52W performance

-24.9%

FCF yield

-24.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AVXL

HURA

Detailed metrics comparison

AVXL

Anavex Life Sciences Corp

HURA

TuHURA Biosciences Inc

Market Cap

AVXL$138M

HURA$125M

Enterprise Value

AVXL$20M

HURA$127M

Price

AVXL$1.49

HURA$1.96

P/E Ratio

AVXLN/A

HURAN/A

P/S Ratio

AVXL0.00x

HURA0.00x

EV/Sales

AVXL0.00x

HURA0.00x

EV/EBITDA

AVXL0.00x

HURA0.00x

P/B Ratio

AVXL1.50x

HURA6.58x

P/FCF Ratio

AVXLN/A

HURAN/A

EV/FCF

AVXL-0.67x

HURA-4.26x

PEG Ratio

AVXLN/A

HURAN/A

Forward P/E (NTM)

AVXLN/A

HURAN/A

Forward P/S (NTM)

AVXLN/A

HURAN/A

Revenue (TTM)

AVXL$0

HURA$0

Revenue Growth (YoY)

AVXLN/A

HURAN/A

Forward Rev Growth

AVXL377.5%

HURA197.3%

Gross Margin (TTM)

AVXL0.0%

HURA0.0%

Operating Margin (TTM)

AVXL0.0%

HURA0.0%

EBITDA Margin (TTM)

AVXL0.0%

HURA0.0%

Net Margin (TTM)

AVXL0.0%

HURA0.0%

FCF Margin (TTM)

AVXLN/A

HURAN/A

Net Income (TTM)

AVXL$-13M

HURA$-31M

FCF (TTM)

AVXL$-29M

HURA$-30M

EPS (TTM)

AVXL-$0.14

HURA-$0.48

ROE (TTM)

AVXL-1143.0%

HURA-15427.0%

ROA (TTM)

AVXL-1072.0%

HURA-10698.0%

ROIC (TTM)

AVXL-1143.0%

HURA-14636.0%

Cash

AVXL$118M

HURA$996K

Debt

AVXL$0

HURA$4M

Net Cash/Debt

AVXL$118M

HURA$-3M

Current Ratio (TTM)

AVXL15.62x

HURA0.18x

Quick Ratio (TTM)

AVXL15.51x

HURA0.16x

Debt/Equity (TTM)

AVXL0.00x

HURA0.19x

Debt/Assets (TTM)

AVXL0.0%

HURA0.0%

Interest Coverage (TTM)

AVXLN/A

HURAN/A

Net Debt/EBITDA (TTM)

AVXL0.00x

HURA0.00x

Beta

AVXL1.20

HURA-0.24

52W Performance

AVXL-84.9%

HURA-24.9%

YTD Performance

AVXL-59.5%

HURA161.3%

% from 52W High

AVXL-85.0%

HURA-42.9%

% from 52W Low

AVXL3.5%

HURA378.0%

Asset Turnover (TTM)

AVXL0.00x

HURA0.00x

FCF Yield (TTM)

AVXL-21.2%

HURA-24.0%

Earnings Yield (TTM)

AVXL-9.4%

HURA-24.5%

Dividend Yield (TTM)

AVXLN/A

HURA0.0%

Rule of 40

AVXL0.0

HURA0.0

EV/GP/RG

AVXLN/A

HURAN/A

Ticker research

View AVXL research View HURA research

Metric	AVXL Anavex Life Sciences Corp	HURA TuHURA Biosciences Inc
Market & Valuation
Market Cap	$138M	$125M
Enterprise Value	$20M	$127M
Price	$1.49	$1.96
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.50x	6.58x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.67x	-4.26x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	377.5%	197.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-13M	$-31M
FCF (TTM)	$-29M	$-30M
EPS (TTM)	-$0.14	-$0.48
ROE (TTM)	-1143.0%	-15427.0%
ROA (TTM)	-1072.0%	-10698.0%
ROIC (TTM)	-1143.0%	-14636.0%
Financial Health
Cash	$118M	$996K
Debt	$0	$4M
Net Cash/Debt	$118M	$-3M
Current Ratio (TTM)	15.62x	0.18x
Quick Ratio (TTM)	15.51x	0.16x
Debt/Equity (TTM)	0.00x	0.19x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	-0.24
52W Performance	-84.9%	-24.9%
YTD Performance	-59.5%	161.3%
% from 52W High	-85.0%	-42.9%
% from 52W Low	3.5%	378.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-21.2%	-24.0%
Earnings Yield (TTM)	-9.4%	-24.5%
Dividend Yield (TTM)	N/A	0.0%
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AVXL research	View HURA research

Valuation

P/S Ratio

AVXL

0.00x

HURA

0.00x

EV/FCF

HURA

-4.26x

AVXL

-0.67x

Growth & revenue

Forward Revenue Growth

AVXL

377.5%

HURA

197.3%

Profitability & performance

Gross Margin

AVXL

0.0%

HURA

0.0%

ROE

AVXL

-1143.0%

HURA

-15427.0%

FCF Yield %

AVXL

-21.2%

HURA

-24.0%

52-Week Performance

HURA

-24.9%

AVXL

-84.9%

Detailed metrics comparison

AVXL

Anavex Life Sciences Corp

HURA

TuHURA Biosciences Inc

Market Cap

AVXL$138M

HURA$125M

Enterprise Value

AVXL$20M

HURA$127M

Price

AVXL$1.49

HURA$1.96

P/E Ratio

AVXLN/A

HURAN/A

P/S Ratio

AVXL0.00x

HURA0.00x

EV/Sales

AVXL0.00x

HURA0.00x

EV/EBITDA

AVXL0.00x

HURA0.00x

P/B Ratio

AVXL1.50x

HURA6.58x

P/FCF Ratio

AVXLN/A

HURAN/A

EV/FCF

AVXL-0.67x

HURA-4.26x

PEG Ratio

AVXLN/A

HURAN/A

Forward P/E (NTM)

AVXLN/A

HURAN/A

Forward P/S (NTM)

AVXLN/A

HURAN/A

Revenue (TTM)

AVXL$0

HURA$0

Revenue Growth (YoY)

AVXLN/A

HURAN/A

Forward Rev Growth

AVXL377.5%

HURA197.3%

Gross Margin (TTM)

AVXL0.0%

HURA0.0%

Operating Margin (TTM)

AVXL0.0%

HURA0.0%

EBITDA Margin (TTM)

AVXL0.0%

HURA0.0%

Net Margin (TTM)

AVXL0.0%

HURA0.0%

FCF Margin (TTM)

AVXLN/A

HURAN/A

Net Income (TTM)

AVXL$-13M

HURA$-31M

FCF (TTM)

AVXL$-29M

HURA$-30M

EPS (TTM)

AVXL-$0.14

HURA-$0.48

ROE (TTM)

AVXL-1143.0%

HURA-15427.0%

ROA (TTM)

AVXL-1072.0%

HURA-10698.0%

ROIC (TTM)

AVXL-1143.0%

HURA-14636.0%

Cash

AVXL$118M

HURA$996K

Debt

AVXL$0

HURA$4M

Net Cash/Debt

AVXL$118M

HURA$-3M

Current Ratio (TTM)

AVXL15.62x

HURA0.18x

Quick Ratio (TTM)

AVXL15.51x

HURA0.16x

Debt/Equity (TTM)

AVXL0.00x

HURA0.19x

Debt/Assets (TTM)

AVXL0.0%

HURA0.0%

Interest Coverage (TTM)

AVXLN/A

HURAN/A

Net Debt/EBITDA (TTM)

AVXL0.00x

HURA0.00x

Beta

AVXL1.20

HURA-0.24

52W Performance

AVXL-84.9%

HURA-24.9%

YTD Performance

AVXL-59.5%

HURA161.3%

% from 52W High

AVXL-85.0%

HURA-42.9%

% from 52W Low

AVXL3.5%

HURA378.0%

Asset Turnover (TTM)

AVXL0.00x

HURA0.00x

FCF Yield (TTM)

AVXL-21.2%

HURA-24.0%

Earnings Yield (TTM)

AVXL-9.4%

HURA-24.5%

Dividend Yield (TTM)

AVXLN/A

HURA0.0%

Rule of 40

AVXL0.0

HURA0.0

EV/GP/RG

AVXLN/A

HURAN/A

Ticker research

View AVXL research View HURA research

Metric	AVXL Anavex Life Sciences Corp	HURA TuHURA Biosciences Inc
Market & Valuation
Market Cap	$138M	$125M
Enterprise Value	$20M	$127M
Price	$1.49	$1.96
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.50x	6.58x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.67x	-4.26x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	377.5%	197.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-13M	$-31M
FCF (TTM)	$-29M	$-30M
EPS (TTM)	-$0.14	-$0.48
ROE (TTM)	-1143.0%	-15427.0%
ROA (TTM)	-1072.0%	-10698.0%
ROIC (TTM)	-1143.0%	-14636.0%
Financial Health
Cash	$118M	$996K
Debt	$0	$4M
Net Cash/Debt	$118M	$-3M
Current Ratio (TTM)	15.62x	0.18x
Quick Ratio (TTM)	15.51x	0.16x
Debt/Equity (TTM)	0.00x	0.19x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	-0.24
52W Performance	-84.9%	-24.9%
YTD Performance	-59.5%	161.3%
% from 52W High	-85.0%	-42.9%
% from 52W Low	3.5%	378.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-21.2%	-24.0%
Earnings Yield (TTM)	-9.4%	-24.5%
Dividend Yield (TTM)	N/A	0.0%
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AVXL research	View HURA research